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An Intronic Enhancer Driven by NF-jB Contributes
to Transcriptional Regulation of Peptidylarginine
Deiminase Type I Gene in Human Keratinocytes
Shibo Ying1,2, Toshio Kojima1,2, Akira Kawada3, Rachida Nachat4, Guy Serre4, Michel Simon4 and
Hidenari Takahara1,2
Peptidylarginine deiminases (PADs) catalyze the conversion of protein-bound arginine to citrulline residues.
In human epidermis, where filaggrin is the main deiminated protein, three PADs are detected with specific
patterns of expression depending on the keratinocyte (KC) differentiation state. Previous characterizations of
the PAD-encoding gene promoters have shown that proximal regulation alone is not sufficient to explain this
specificity of expression. In this work, we describe an evolutionarily highly conserved nucleotide segment
located in the first intron of the PAD1 gene (PADI1). Luciferase reporter assays showed that it enhances the
activity of the PADI1 promoter, in a calcium- and orientation-independent manner. Mutation of a putative NF-kB
cis-element markedly reduced its enhancer activity, which also confirmed its potential regulatory function.
Chromatin immunoprecipitation assays evidenced the binding of both p65 and p50 NF-kB subunits to the
cis-element, and RNA interference inhibition assays confirmed that NF-kB contributes to the PADI1
transcriptional control. Furthermore, the intronic enhancer and promoter of PADI1 potentially interact through
chromatin looping, as indicated by chromosome conformation capture assays. Our findings provide evidence
that an NF-kB-mediated signaling pathway is involved in PADI1 regulation in human epidermal KCs.
Journal of Investigative Dermatology (2010) 130, 2543–2552; doi:10.1038/jid.2010.179; published online 1 July 2010
INTRODUCTION
Peptidylarginine deiminase (PAD; EC 3.5.3.15) has been
found as the enzyme that catalyzes deimination, the
conversion of protein-bound arginine residues to citrulline
residues in the presence of calcium ions. Deimination has
been recently implicated in several epidermal physiological
and pathological processes (Vossenaar et al., 2003; Ying
et al., 2009). In particular, deimination of filaggrin is a critical
step in the production of a pool of amino acids necessary
for epidermal barrier function (Kamata et al., 2009). PAD1 is
thought to be the only isoform responsible for keratin K1 and
K10 deimination in the upper stratum corneum (Chavanas
et al., 2006). The importance of the protein has been recently
evidenced by the description of loss-of-function mutations in
the filaggrin gene that underlie ichthyosis vulgaris (OMIM
146700) and are strongly linked to atopic dermatitis (OMIM
603165) susceptibility (Palmer et al., 2006; Smith et al.,
2006). Deimination is also crucial for the properties of
trichohyalin and S100A3, two major proteins of the hair
follicles (Tarcsa et al., 1997; Kizawa et al., 2008). Moreover,
a decreased level of keratin deimination has been described
in the epidermis of patients with psoriasis (OMIM 177900)
and bullous congenital ichthyosiform erythroderma (OMIM
113800) (Ishida-Yamamoto et al., 2000, 2002).
Five human PADI genes, which encode five isotypes
named PAD1, 2, 3, 4, and 6, are located at a single cluster
spanning a region of about 355 kb in length on chromosome
1p36.1 (Chavanas et al., 2004). Although all PADI genes
share significant identities at the level of their coding
nucleotide sequences, the mechanisms responsible for their
patterns of expression have been suspected to diverge. In the
epidermis, PAD1 is expressed in the entire tissue from the
basal to the granular layer. PAD2 is mainly detected in both
the spinous and granular layers, whereas PAD3 expression is
restricted to the granular layer and lower stratum corneum.
Moreover, PAD4 and 6 have not been detected (Me´chin
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et al., 2005; Nachat et al., 2005b). These different patterns of
expression strongly suggest that the expression of each PADI
gene is tightly controlled during keratinocyte (KC) differen-
tiation. To elucidate the regulatory mechanisms involved,
we have previously focused on the characterization of the
PADI1-3 gene proximal promoters (Ying et al., 2009), and on
the transcription factors bound to these regulatory elements
in cultured normal human epidermal keratinocytes (NHEKs).
Nevertheless, these data do not completely explain the
tissue- and cell-differentiation-specific expression of the
PADI1 gene.
More recently, several studies have shown that NF-kB
binding to intronic enhancer elements has a significant role in
gene transcription (Schjerven et al., 2001; Liu et al., 2007;
Xue et al., 2009). Otherwise, NF-kB has been connected to
KC proliferation, differentiation, and senescence in human
skin as is well known (Bell et al., 2003). In this study, we
provide evidence that both p50 and p65 NF-kB subunits
directly bind to a cis-element identified within the first intron
of the PADI1 gene, and both are critical for the in vivo
expression of this gene through transcriptional regulatory
mechanisms.
RESULTS
Identification of a conserved noncoding sequence in the first
intron of the human PADI1 gene
Multispecies comparison of PADI1 genomic sequences
revealed a highly conserved sequence within an approxi-
mately 1,000 bp sequence of the gene’s first intron, as shown
in Supplementary Figure S1 online. Because interspecies
conservation often is predictive of a biological role, we
suspected that this conserved noncoding sequence (CNS)
contains a functional cis-element acting on PADI1 transcrip-
tion. Because it is located in the first intron of the gene, we
named it CNSi.
To test a putative transcriptional activation effect of CNSi,
it was subcloned into a luciferase reporter vector containing
the PADI1 core promoter (195/þ84 region), and we carried
out luciferase assays using NHEKs. The cells were grown
in the presence of 0.2mM (proliferative condition) or 1.5mM
(differentiation condition) calcium in culture medium. They
were transfected with reporter plasmids containing either the
full-length 975 bp CNSi or restriction fragments of it. The
whole CNSi and all constructions containing the fragment 2
(267 bp; nucleotides 310–576) induced a twofold increase
in the activity of the PADI1 promoter when NHEKs
were cultured in both low- and high-calcium conditions
(Figure 1a). The constructs containing only fragment 1
(nucleotides 1–309) or 3 (nucleotides 577–975) did not show
any significant effect. When CNSi fragment 2 was cloned in
the opposite orientation, it also showed a twofold enhance-
ment of the PADI1 promoter activity (Figure 1b). In further
experiments, fragment 2 was also observed to significantly
enhance the activity of an SV40 virus promoter in an
orientation-independent manner, but with fewer efficacies
(Figure 1b). Therefore, fragment 2 seemed to contain a typical
intronic enhancer. Although the PADI1 core promoter was
shown to be calcium responsive for PADI1 gene transcription
(Dong et al., 2008), the intronic enhancer was slightly
affected in response to calcium stimulation.
These data suggest that some intronic enhancer elements
are likely present in the CNSi fragment 2.
A putative NF-jB-binding site in the CNSi fragment 2 is an
intronic enhancer
To further elucidate the characteristics of the CNSi fragment
2, we searched for putative transcription factor-binding sites
using the P-Match database (http://www.gene-regulation.
com). There was an area that closely matched the consensus
sequences recognized by NF-kB, ELK1, and CREL, suggesting
that these transcription factors could be involved in the
regulation of PADI1 promoter activity (Figure 2a). Luciferase
assays using constructs bearing mutations of these candidate-
binding sites were carried out (Figure 2b). Luciferase activities
were reduced by about 40% when the putative NF-kB-
binding site was mutated as compared with the wild type,
whereas mutations of the two other sites had no effect. To
confirm the putative NF-kB cis-element, we carried out
NoShift transcription factor assays using nuclear extracts
prepared from NHEKs cultured in high-calcium-containing
medium. In competition analysis shown in Figure 2c, NF-kB
binding was completely blocked by a 50-fold molar excess of
the nonbiotinylated synthetic oligonucleotides containing the
wild-type putative NF-kB-binding site, showing sequence
specificity of the assay for NF-kB binding. However, the
probes corresponding to the mutated putative NF-kB-binding
site failed to compete. These results strongly suggest that the
cis-element binding by NF-kB found within the fragment 2
region may be critical for PADI1 promoter activity as an
intronic enhancer.
Both p50 and p65 bind to the intronic NF-jB cis-element
To ascertain whether the transcription factor NF-kB main
subunits, namely p50 and p65, actually bind to their
predicted binding site within the first intron of PADI1
in vivo, we carried out chromatin immunoprecipitation
(ChIP) assays using anti-p50 and anti-p65 antibodies, with
specific primers for the CNSi, and for the core-promoter
region and exon 2 of PADI1 gene (Figure 3a). Before the
ChIP assays, the chromatin was sonicated in fragments of
approximately 500 bp on average. As shown in Figure 3b,
both NF-kB p50 and p65 proteins were highly detected at the
intron 1 region. The bindings were not evidently affected
when nuclei were prepared from KCs cultured in high- versus
low-calcium-containing medium. When PCR was carried out
on the chromatin samples immunoprecipitated with non-
immune IgG using the same primers, no PCR signals were
observed, showing the specificity of binding. Further speci-
ficity of the ChIP analysis was shown by the inability to detect
binding of p50 or p65 to exon 2 of the PADI1 gene (Figure
3b). Moreover, no PCR signal was observed using primers
over 1.5 kb of the 50-flanking region (data not shown).
Interestingly, in the core-promoter region, the binding of
NF-kB p50 and p65 proteins was also slightly detected.
Therefore, these results raised the possibility that NF-kB
complexes located in the intronic region show mutual
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interactions with other transcriptional complexes bound to or
with elements in the core promoter of PADI1.
Altogether, these findings suggest that the association of
NF-kB p50 and p65 on the intronic region of PADI1 may
have a prominent role in transcription.
Expression of NF-jB is crucial for PADI1 transcription
We next carried out small interfering RNA (siRNA) and tumor
necrosis factor (TNF)-a stimulation experiments to investigate
the in vivo role of NF-kB p50 and p65 in PADI1 gene
regulation. As shown in Figure 4a, siRNA transfections
hindered the synthesis of each transcription factor and
PAD1 in NHEKs in a specific manner. When p50 expression
was reduced by specific siRNA transfection, the level of
endogeneous PADI1 mRNAs in the cells cultured in both
low- and high-calcium-containing medium was diminished
by about 40%. Similarly, the level of PADI1 mRNAs was
diminished by over 30%, according p65 knockdown in both
conditions (Figure 4b). The endogenous PADI1 expression
was reduced by over 50% by the knockdown effect of a
combined siRNA-p50 and siRNA-p65. Control siRNA did not
significantly affect PADI1 expression. TNF-a is a cytokine
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Figure 1. CNSi enhances the activity of the PADI1 minimal promoter in cultured keratinocytes (KCs). Normal human epidermal keratinocytes (NHEKs)
cultured in 1.5mM (black bars) or 0.2mM (hatched bars) calcium-containing medium were cotransfected with firefly luciferase (luc) reporter plasmids containing
the entire CNSi or fragments of CNSi upstream of either the PADI1 minimal promoter or the SV40 promoter as indicated. Luciferase activities were measured
48hours after transfections. Luciferase activities are expressed as fold-increase over promoterless vector, pGBasic (set as 1). (a) CNSi and some fragments
of CNSi enhance the activity of PADI1 core promoter in cultured KCs. (b) Orientation-independent effects of the CNSi fragment 2 (nucleotides 310–576). Values
were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid, and are expressed as mean ± SD from four separate
experiments. **Po0.01 versus the difference between luciferase activity of reporter plasmids containing PADI1 core promoter (or SV40 promoter) alone
and others in each condition. (Student’s t-test).
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well known to activate and induce the nuclear translocation
of NF-kB in KCs (Takao et al., 2003; Sun et al., 2004). Though
the level of NF-kB subunits observed was not obviously
modified after stimulation with TNF-a in cultured KCs (Figure
4a), the likely activation actually increased endogenous
PADI1 gene expression by about twofold, observed in both
low- and high-calcium conditions (Figure 4b).
Using luciferase assays, we also evaluated the effect of
NF-kB p50 and p65 knockdown on the enhancer activity
of the CNSi fragment 2. We used the mock of PADI1 core
promoter alone as control. As shown in Figure 4c, the
expression of the pGB/CNSi-Fragment2 luciferase reporter
gene was reduced (by about 20–45%) by cotransfections
with either siRNA-p50, siRNA-p65, or both. The effects
were observed in NHEKs cultured in both low- and
high-calcium conditions. Besides, TNF-a treatment
increased the pGB/CNSi-Fragment2 reporter activity in
cultured KCs.
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Figure 2. An intronic NF-jB cis-element enhances the activity of the PADI1 minimal promoter. (a) Sequence and putative transcription factor-binding sites
of the CNSi fragment 2 (nucleotides 310–576) in human PADI1 and mouse PADI1 genes. Putative transcription factor-binding sites predicted using the BIOBASE
P-Match-public v1.0 (http://www.gene-regulation.com) are underlined. (b) Characterization of the transcription factor-binding sites in the PADI1 CNSi fragment
2 by site-directed mutagenesis. Shown is the schematic diagram of serial mutation constructs and their luciferase activities in normal human epidermal
keratinocyte (NHEKs) cultured in high-calcium-containing medium. The targeted putative transcription factor-binding sites are shown on the constructs
with a solid cross. Values were corrected for transfection efficiency by cotransfection with the Renilla expression plasmid, and are expressed as mean ± SD
from four separate experiments. *Po0.05, significantly different from wild type (WT) (Student’s t-test). (c) Site-directed mutagenesis of putative NF-kB-binding
sites and its inhibitive effect on the binding shown by the NoShift transcription factor assay. Nuclear extracts were harvested from NHEKs cultured in high-
calcium-containing medium. Binding activity assessed by biotinylated NF-kB wild-type or mutant NF-kB consensus-binding motif double-stranded DNA
(Mut) probes plus their nonbiontinylated competitor DNA in a 50-fold molar excess. A positive control with no competitor DNA was also included
(lanes 1 and 4). Negative control (Neg) consisted of reactions carried out in the absence of a binding sequence. All assays were carried out in triplicate.
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Taken together, these data show that the expression of
NF-kB p50 and p65 is crucial for the transcription of PADI1
in NHEKs.
Potential interactions between PADI1 promoter and CNSi
To validate the hypothesis that CNSi directly interacts with
the promoter of PADI1, we carried out chromosome
conformation capture assays for a nonrandom chromatin
looping mechanism (Dekker et al., 2002). The nuclei
prepared from NHEKs were mock treated, or transfected by
combined p50/p65-siRNA, or stimulated by TNF-a, and were
then cross-linked with formaldehyde to fix segments of
genomic DNA that are in physical proximity in vivo. The
cross-linked DNA was then digested with BglII, because there
are two BglII sites within the promoter to CNSi along the 2 kb
region of the human PADI1 gene (Figure 5a). The DNA was
ligated at a low concentration, and the ligated DNA obtained
was then analyzed by PCR using primer pairs designed to
span each of two BglII sites (Figure 5b). The presence of a
positive PCR product, the nature of which was confirmed by
sequencing (Supplementary Figure S2), indicated successful
ligation and thereby DNA looping. To exclude the possibility
that the observed PCR products were a result of random
collisions due to the inherent flexibility of chromatin, we
also analyzed unligated samples after overnight BglII treat-
ment, and failed to detect the PCR-amplified corresponding
bands (Figure 5b, lanes 2, 3, and 4). The interaction also
did not occur when the same assay was carried out with
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Figure 3. p50 and p65 bind to the intronic NF-jB cis-element of PADI1 in vivo. Chromatin immunoprecipitation (ChIP) assays using anti-p50, anti-p65,
or IgG control were carried out on chromatin from normal human epidermal keratinocytes (NHEKs) cultured in low- (L) or high- (H) calcium-containing
medium. (a) The positions of the ChIP primer sets are indicated above the schematic organization of the PADI1 gene, including the core promoter with
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(lower panel, negative control). (c) For quantitative analyses of p50 and p65 binding to the CNSi, as well as core promoter, the samples from NHEKs cultured
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described in the Materials and Methods section.
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purified genomic DNA (data not shown). The relative
efficiency of loop detection was reduced by 50% after
cotransfection of NHEKs with siRNA-p50 and siRNA-p65,
as compared with mock-transfected cells. In contrast, the
looping efficiency was increased by over twofold when the
KCs were treated with TNF-a (Figure 5c). The results strongly
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Figure 4. Expression of NF-jB is crucial for PADI1 endogenous expression in normal human epidermal keratinocytes (NHEKs). NHEKs were transfected
with 100 nM of the indicated siRNA and cultured for 36 h, or stimulated by tumor necrosis factor (TNF)-a (10 ngml1) for 2 hours. Nuclear proteins, total RNA,
and cell lysates were extracted for western blotting (a) with the indicated antibodies (anti-NF-kB p50, anti-NF-kB p65, anti-PAD1, or anti-Histone H1),
quantitative reverse-transcription PCR analysis (b), and luciferase (luc) reporter analysis (c), respectively. (a) Inhibition of expression of NF-kB p50 and p65 with
their respective specific siRNA, including combined si-p50/p65, was confirmed by western blotting, as compared with si-Control. Activation of expression of
NF-kB p50 and p65 stimulated by TNF-a was also confirmed by western blotting, as compared with mock. Histone H1 served as a loading control. Similar
results were obtained with low- or high-calcium treatments. (b) Effects of NF-kB p50 and p65 on endogenous PADI1 expression. PADI1 expression levels in
NHEKs cultured in low (hatched bars) and high (black bars) calcium-containing medium were normalized to the levels of expression of the internal control
glyceraldehyde-3-phosphate dehydrogenase, and expressed relative to the nontreated NHEKs cultured in low-calcium-containing medium. Results are
mean ±SD from four experiments. *Po0.05, **Po0.01 versus si-Control group (Student’s t-test). (c) Relative luciferase activity in NHEKs transfected
with the indicated siRNA and cotransfected with the reporter gene vector CNSi/Fragment2. NHEKs cultured in low (hatched bars) and high (black bars)
calcium-containing medium. Results are mean ±SD from four experiments. *Po0.05, **Po0.01 versus si-Control group (Student’s t-test).
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suggested that the looping efficiency is influenced by either
the inhibition or the activation of NF-kB.
Therefore, we concluded that the CNSi and promoter of
PADI1 gene may interact through NF-kB by a specific
chromatin loop.
DISCUSSION
It is well known that highly conserved cis-regulatory regions are
preferentially linked to developmental regulatory genes such as
transcription factors, certain cell communication signals, and
chromatin attachment sites in vertebrates (Adams, 2005; Woolfe
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Figure 5. Interaction between the promoter and CNSi of human PADI1 gene indicating intrachromatin looping. (a) The chimeric DNAs containing CNSi and
the promoter region of PADI1 were explored by chromosome conformation capture analysis using specific primers. The positions of the two BglII restriction sites
(perpendicular lines) are indicated along the 2 kb region between the promoter and CNSi of the human PADI1 gene. Arrows represent the primers used in PCR.
Exon 1 and 2 are shown as boxes. F and R mean forward and reverse primer, respectively. (b) High potential interaction between the promoter and CNSi
indicating chromatin looping. Chromatin from cross-linked normal human epidermal keratinocytes (NHEKs) was digested with excessive amounts of BglII
restriction enzyme and diluted for intramolecular ligation. Purified DNA fragments were assayed by conventional PCR. NHEKs were mock treated (lanes 2
and 5), transfected by combined p50/p65-siRNA (lanes 3 and 6), or stimulated for 2 hours by tumor necrosis factor (TNF)-a (10 ngml1; lanes 4 and 7).
Random ligation control templates were generated by amplifying the human genomic DNA fragment with primers that span the BglII sites. Equimolar amounts
of PCR products were mixed and digested with BglII overnight. Ligated DNA was used to generate control PCR products by using a combination of the
primer pairs to monitor the efficiency of ligation (lane 1). BglII-digested chromosomal DNA was used as a template for PCR to examine the efficiency of
BglII digestion (lanes 2, 3, and 4). Ligated templates after dilution were used to PCR amplify after BglII digestion and ligation (lanes 5, 6, and 7). Input DNA
was used as an internal control for PCR on CNSi. All PCR products were examined on 2% agarose gel stained with ethidium bromide and confirmed by
sequencing as indicated in Supplementary Figure S2. All primers used are listed in Supplementary Table S1. See Materials and Methods section for additional
information. (c) Relative efficiency of looping from mock-transfected, siRNA-transfected, and TNF-a-treated cells. The PCR products (lanes 5, 6, and 7)
were quantified after scanning using the ‘‘Quantity One’’ software package (version 4.2; Bio-Rad). The values are expressed relative to that obtained
from mock-transfected keratinocytes. They correspond to the averages from three experiments with standard deviations.
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and Elgar, 2008). They are not only located upstream of the
promoters but are also found in downstream introns and even
within transcribed regions. Moreover, some intronic cis-elements
are reported to function as switches to either control the on/off
state of genes in particular cell types or to regulate gene
expression levels to adapt to changing physiological conditions
and environmental influences (Stra¨hle and Rastegar, 2008).
Thus, the overall expression profile of a particular gene may be
the result of the presence of multiple regulatory modules. In this
study, we provide convincing evidence for the direct interaction
of NF-kB with an intronic CNS of the PADI1 gene, which
ultimately enhances the transcription of this gene in KCs.
The CNSi is the most highly conserved region of all introns
of PADI1. Further comparison of an approximately 250-nucleo-
tide core functional region of PADI1, and Padi1, the mouse
orthologous gene, revealed extensive homology, including an
NF-kB putative binding site that was the most confident, with a
P-value of 1.0 in the in silico motif search. The enhancer
properties of this segment on the core promoter of PADI1 were
evidenced by functional analyses. In particular, the binding to
this motif of both NF-kB p50 and p65 was shown, as well as the
importance of this binding for the expression of the endogenous
PADI1 gene in KCs. As is well known, NF-kB or components
of the NF-kB pathway seem to be involved in epidermal
morphogenesis and homeostasis (Bell et al., 2003). In agree-
ment with the hypothesis of NF-kB involvement in the
regulation of PADI1, the expression of the two subunits of
NF-kB, p50 and p65 has been detected in the entire human
epidermis from the basal to the granular layer, a pattern that is
very similar to the expression of PADI1 (Takao et al., 2003; Sun
et al., 2004). Moreover, a few recent studies reported that
NF-kB binding sequences within noncoding introns are
involved in the transcription of several genes (Ge et al., 2003;
Cleynen et al., 2007; Liu et al., 2007; Xue et al., 2009).
Incidentally, NF-kB p65-binding sites were detected in the first
intron (12%) or in more internal introns (28%) of a significant
proportion of the genes annotated across human chromosome
22 (Martone et al., 2003). In addition, perturbations of both NF-
kB and PAD1 activities are also linked to developmental skin
defects, inflammatory skin disease, and skin cancer (Bell et al.,
2003; Chavanas et al., 2006). For example, a reduction in
deiminated keratin K1 has been reported in the involved areas
of the epidermis of psoriatic patients (Ishida-Yamamoto et al.,
2000), and a recent study has shown an increase in NF-kB
expression in the skin of patients with psoriasis (Bell et al.,
2003; Lizzul et al., 2005). This raises the possibility that the
NF-kB-mediated pathway is associated with the expression of
PADI1. Certainly, validation of the involved signaling pathways
will require further investigation. To our knowledge, that the
NF-kB-mediated signaling pathway is involved in PAD
regulation in human epidermis is previously unreported.
The intronic location of the NF-kB cis-element leads to an
intriguing question about how the regulatory elements
communicate downstream from the promoter to contribute
to transcriptional regulation. Recently, it has been shown that
the packaging of eukaryotic DNA into nucleosomes and
higher order structures of chromatin facilitates direct inter-
action or communication, through bridging molecules,
between distant regulatory regions (Bartkuhn and Renkawitz,
2008). In our previous studies, we have evidenced that long-
range (86 kb) enhancers and chromatin looping allow control
of PADI3 expression during KC differentiation (Adoue et al.,
2008; Chavanas et al., 2008). The PADI1 gene is located
between the PADI3 promoter and these enhancers (Chavanas
et al., 2004). Thus, it is possible that physical interactions
exist between NF-kB and certain cis-elements of the
promoter or the RNA polymerase II preinitiation complex
(Figure 6). For another example, the induction of the
monocyte chemoattractant protein 1 gene occurs through
an NF-kB-dependent distal regulatory region and an Sp1-
dependent proximal regulatory region that are separated by
2.2 kb (Boekhoudt et al., 2003). This strongly supports the
hypothesis that Sp1, which has also been found to bind to the
core promoter of PADI1 (Dong et al., 2008), is required
for NF-kB binding and some histone modifications of the
Intronic CNSi
Core promoter
p65
p50
Pol II
TBP MZF1 Sp1 MZF1PADI1
PADI1
PADI 2
PADI3
2.5 kb
40
 k
b 40 kb
Nucleus
44 k
b
NF-κB-mediated pathway
Promoter CNS Interplay/communication
Transcription complex
Figure 6. Hypothetical model of the transcriptional regulation of human
PADI1 gene by cross talk between its promoter and an NF-jB-mediated
signaling pathway in normal human epidermal keratinocytes (NHEKs). This
study shows that both p65 and p50 bind to a cis-element in a conserved
noncoding sequence of the first intron of the PADI1 gene (CNSi), and interact
with the transcription complex on the gene core promoter in the upper domain.
It suggests that this interaction contributes to the control of PADI1 transcription
in human keratinocytes. The lower domain of the schematic representation
denotes PADI3 transcription regulation through a long-range chromatin loop
and a long-distance enhancer, as reported previously (Adoue et al., 2008;
Chavanas et al., 2008). Please note that the distance between genes and the
length of PADI1 are approximations. Please refer to text for details. TBP, TATA-
box binding protein; pol II, RNA polymerase II complex.
2550 Journal of Investigative Dermatology (2010), Volume 130
S Ying et al.
Transcriptional Regulation of PADI1 Gene in Human KCs
distal region for their interaction (Teferedegne et al., 2006).
As was our prediction, chromosome conformation capture
assay results provide conclusive evidence of a high potential
for interaction between the intronic CNSi and PADI1 gene
promoter by way of chromatin looping. Therefore, TNF-a-
mediated signaling by two different pathways could not only
regulate NF-kB, but also might control Sp1 activity, and
hence we speculate that TNF-a stimulation of looping
efficiency produces a duplex effect (Kuwahara et al., 2007;
Park et al., 2009).
In summary, this work shows that an intronic enhancer
driven by NF-kB contributes to transcriptional regulation of
PADI1 in human KCs by intrachromatin looping. Epidermal
homeostasis requires a balance of pro- and anti-proliferative
signals in addition to survival signals (Mu¨ller et al., 2008). The
biosynthesis of PADI members may be under the control of
multiple complex regulatory mechanisms in response to
relevant extracellular stimuli, including the NF-kB-mediated
signaling pathway. Further investigations of the interdependent
signaling pathways between PADI1 and NF-kB during epider-
mal renewal will contribute to a better understanding of their
complex interplay and will provide insights into the mechan-
isms underlying their potential involvement in skin diseases.
MATERIALS AND METHODS
All experiments were conducted in accordance with the Declaration
of Helsinki Principles and were approved by Ibaraki University
Ethical Committee of Human Genome and Gene Research in Japan.
Comparative genomic and transcriptional motif analysis
The section of in silico assay is provided as Supplementary Materials
and Methods.
Cell cultures
NHEKs were obtained from Clonetics and cultured in KGM2 medium
(Clonetics, San Diego, CA) with either 0.15mM (proliferating condition)
or 1.2mM (differentiating condition) Ca2þ as described previously
(Hennings et al., 1980). Unless specifically indicated, NHEKs were
exposed to 1.2mM Ca2þ for 96 hours to induce differentiation. All
cells were incubated at 37 1C with 5% CO2. After reaching 70–80%
confluence, the cells were collected for stimulation by 10 ngml1
human recombinant TNF-a (Wako, Osaka, Japan) for 2 hours, or for
transfection.
Quantitative real-time PCR analysis
RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA).
Real-time PCR was carried out using SuperScript III Platinum two-
step quantitative reverse-transcription PCR (Invitrogen) and iCycler
IQ detection system (Bio-Rad, Hercules, CA) as described previously
(Dong et al., 2005). The amount of complementary DNA was
normalized in PCR control reactions with primers specific for
glyceraldehyde-3-phosphate dehydrogenase. All primers used in this
work are listed in Supplementary Table S1.
Construction of reporter vectors and mutagenesis experiments
Detailed protocols for construction of reporter vectors and mutagen-
esis experiments are provided as Supplementary Materials and
Methods.
Transfection and measurement of relative activity
Transfection and measurement of experiments were carried out
following procedures described previously (Dong et al., 2005).
Luciferase activity is expressed as fold-induction over the empty
pGBasic (set as 1). Four transfections were carried out independently
for each construct, and the results were expressed as mean ± SD.
NoShift transcription factor assay
Detailed protocol for the NoShift transcription factor assay is
provided as Supplementary Materials and Methods.
ChIP assays
In brief, ChIP assays were carried out as described in the protocol of
the Red ChIP Kit (Diagenode, Liege, Belgium). Immunoprecipitation
was performed overnight with agitation at 4 1C with 5mg of normal
IgG, anti-p50, or anti-p65 antibodies (Santa Cruz Biotechnology,
Santa Cruz, CA). Real-time PCR was used to amplify the PADI1 core-
promoter region, exon 2 region, and the putative intronic NF-kB
cis-element region (Figure 3a). The primers used for the ChIP assays
are listed in Supplementary Table S1. The amplification program of
quantitative PCR consisted of denaturation at 95 1C for 3minutes,
followed by 50 cycles at 95 1C for 30 seconds, and at 60 1C for
30 seconds. The quality of the ChIP was deduced from the yield
recovery, calculated as the percentage of chromatin inputs
coprecipitated, and from the specificity occupancy calculated as
fold-enrichment over the PADI1 exon 2 chosen as the nonbinding
control region.
siRNA-based inhibition
NHEKs were transfected using the siRNA transfection reagent
with 100 nM NF-kB p50-siRNA(h), NF-kB p65-siRNA(h), or
Control siRNA-A (Santa Cruz Biotechnology), according to the
manufacturer’s instructions. After culturing in antibiotic-free
medium for 48 hours, total RNA was extracted by TRIzol Reagent
(Invitrogen) and analyzed by quantitative reverse-transcription
PCR as described above. To confirm the specific inhibitory
activity of each siRNA, we carried out western blotting analyses
with the antibodies against each transcription factor as described
below.
Western blotting
The nuclear extracts were prepared as described in the manufac-
turer’s instructions of NucBuster protein extraction kit (Novagen,
Madison, WI) from untreated or siRNA-transfected cells. Anti-NF-kB
p50 (H-119), anti-NF-kB p65 (C-20), or anti-Histone H1 (FL-219)
(Santa Cruz Biotechnology), and anti-PAD1 (Nachat et al., 2005b)
were added in skim milk solution at a sufficient dilution
(1:200–1:10,000). The secondary anti-rabbit (Santa Cruz Biotechnol-
ogy) antibody was used at a dilution of 1:3,000. The proteins were
detected using Enhanced Chemiluminescence plus Western Blotting
Detection System (Amersham Pharmacia Biotech, Arlington Heights, IL).
Chromosome conformation capture assay
A detailed protocol, for chromosome conformation capture in
NHEKs, is provided as Supplementary Materials and Methods.
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